Location History:
- Havana, CU (2013)
- Ciudad de La Hababa, CU (2013)
Company Filing History:
Years Active: 2013
Title: Innovations by Gabriel Ramon Padron Palomares
Introduction
Gabriel Ramon Padron Palomares is an accomplished inventor based in Havana, Cuba. With a focus on medical applications, he holds two patents that showcase his innovative contributions to healthcare and biotechnology.
Latest Patents
One of his significant inventions is a method to block the infection by flaviviruses. This invention specifically addresses the issue of dengue virus, proposing a novel approach that interferes with the interaction between the viral envelope protein and the alpha-2 macroglobulin receptor, a critical component in the infection process. This method has profound implications for preventing dengue virus infections.
His second patent involves a method of inducing T cell apoptosis by administering an Altered Peptide Ligand (APL). This innovation is especially relevant in the field of medicine, particularly for treating Crohn's disease, ulcerative colitis, and type 1 diabetes. The peptide derived from the human heat shock protein promotes apoptosis in specific immune cells, providing a potential therapeutic avenue for patients suffering from these conditions.
Career Highlights
Gabriel is currently associated with the Center for Genetic Engineering and Biotechnology, where his expertise in genetic engineering and biotechnological advancements is instrumental in driving innovative research and development projects. His work aims to push the boundaries of medical treatments and enhance patient outcomes.
Collaborations
Throughout his career, Gabriel has collaborated with notable colleagues such as Vivian Huerta Galindo and Glay Chinea Santiago, contributing to a dynamic research environment that fosters innovation and discovery. These collaborations have facilitated the development of groundbreaking solutions in the fields of genetics and medicine.
Conclusion
Gabriel Ramon Padron Palomares exemplifies the spirit of innovation in medicine and biotechnology. His patents highlight the potential for advancements that can significantly impact public health. As he continues his work at the Center for Genetic Engineering and Biotechnology, the medical community eagerly anticipates his future contributions to the field.